Prof. Dr. Ibrahim Yakoub-Agha, Head of the Hematopoietic Cell Transplantation Unit at Lille University Hospital, explains the safety updates.
The video is in French.
active
Prof. Dr. Ibrahim Yakoub-Agha, Head of the Hematopoietic Cell ...
Prof. Dr. Ibrahim Yakoub-Agha, Head of the Hematopoietic Cell Transplantation Unit at Lille University Hospital, explains the safety updates.
The video is in French.
active
Prof. Dr. Ibrahim Yakoub-Agha, Head of the Hematopoietic Cell ...
Prof. Dr. Ibrahim Yakoub-Agha, Head of the Hematopoietic Cell Transplantation Unit at Lille University Hospital, explains the safety updates.
The video is in English.
active
Dr. Bruno Paiva, Scientific Coordinator of the Diagnostic Laboratories ...
Dr. Bruno Paiva, Scientific Coordinator of the Diagnostic Laboratories of the University of Navarra (Spain), explains what immune monitoring is.
The video is in Spanish.
active
Dr. Bruno Paiva, Scientific Coordinator of the Diagnostic Laboratories ...
Dr. Bruno Paiva, Scientific Coordinator of the Diagnostic Laboratories of the University of Navarra (Spain), explains what immune monitoring is.
The video is in English.
active
Prof. Dr. Halvard B. Bönig, Research and Development Department ...
Prof. Dr. Halvard B. Bönig, Research and Development Department Translational Cell Therapy Development/GMP, explains the manufacturing process of the CARAMBA CAR-T treatment.
The interview is in German.
active
Prof. Dr. Halvard B. Bönig, Research and Development Department ...
Prof. Dr. Halvard B. Bönig, Research and Development Department Translational Cell Therapy Development/GMP, explains the manufacturing process of the CARAMBA CAR-T treatment.
The interview is in English.
active
In this video, Dr Sonja Zweegman, Amsterdam University Medical ...
In this video, Dr Sonja Zweegman, Amsterdam University Medical Centers, Cancer Centers Amsterdam, the Netherlands, and member of the Myeloma Patients Europe (MPE) Medical Advisory Committee, explains the updates for ...frail and high-risk patients presented at ASH 2022.[+] Show More
active
In this video, Dr Sonja Zweegman, Amsterdam University Medical ...
In this video, Dr Sonja Zweegman, Amsterdam University Medical Centers, Cancer Centers Amsterdam, the Netherlands, and member of the Myeloma Patients Europe (MPE) Medical Advisory Committee, explains the myeloma updates ...and the data she and her team presented at ASH 2022.[+] Show More
active
Professor Efstathios Kastritis, Associate Professor at the National ...
Professor Efstathios Kastritis, Associate Professor at the National and Kapodistrian University of Athens, Athens, Greece, and member of the Myeloma Patients Europe (MPE) Medical Advisory Committee, explains if CAR T-cell ...therapy is being explored for the treatment of AL amyloidosis.[+] Show More
active
Professor Efstathios Kastritis, Associate Professor at the National ...
Professor Efstathios Kastritis, Associate Professor at the National and Kapodistrian University of Athens, Athens, Greece, explains the main AL amyloidosis highlights presented at ASH 2022.
active
In this video, Dr Charlotte Pawlyn, Haematology Consultant, Royal ...
In this video, Dr Charlotte Pawlyn, Haematology Consultant, Royal Marsden Hospital, London, and member of the Myeloma Patients Europe (MPE) Medical Advisory Committee, explains the latest bispecific antibodies updates presented ...at ASH 2022.[+] Show More
active
Dr Roman Hajek, Head of the Department of Clinical Hematooncology, ...
Dr Roman Hajek, Head of the Department of Clinical Hematooncology, University Hospital Ostrava, Czech Republic, explains in this video the key highlights presented at the American Society of Hematology annual ...meeting 2022.[+] Show More
